EBP50 inhibits EGF-induced breast cancer cell proliferation by blocking EGFR phosphorylation

Amino Acids

Volumn 43, Issue 5, 2012, Pages 2027-2035

  Yao, Wenfang ^a,b   Feng, Duiping ^a,b   Bian, Weihua ^a   Yang, Longyan ^a   Li, Yang ^a   Yang, Zhiyu ^a   Xiong, Ying ^a   Zheng, Junfang ^a   Zhai, Renyou ^b   He, Junqi ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; EBP50; EGFR; ERK1 2; PDZ; Phosphorylation; Protein interaction

Indexed keywords

ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; EZRIN RADIXIN MOESIN BINDING PHOSPHOPROTEIN 50; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL CULTURE; CANCER GROWTH; CELL PROLIFERATION; CELL STIMULATION; CELL STRAIN MCF 7; CELL STRAIN MDA MB 231; CONTROLLED STUDY; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RECEPTOR UPREGULATION; STABLE EXPRESSION;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; EPIDERMAL GROWTH FACTOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHOPROTEINS; PHOSPHORYLATION; PLASMIDS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SODIUM-HYDROGEN ANTIPORTER; TRANSFECTION;

EID: 84868137932     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-012-1277-z     Document Type: Article

References (41)

1. Barton S, Starling N, Swanton C (2010) Predictive molecular markers of response to epidermal growth factor receptor(EGFR) family-targeted therapies. Curr Cancer Drug Targets 10(8):799-812
2. Chen W, Martindale JL, Holbrook NJ, Liu Y (1998) Tumor promoter arsenite activates extracellular signal-regulated kinase through a signaling pathway mediated by epidermal growth factor receptor and Shc. Mol Cell Biol 18(9):5178-5188 (Pubitemid 28388101)
3. Cheng S, Zhang J, Zhu P, Ma Y, Xiong Y, Sun L, Xu J, Zhang H, He J (2010) The PDZ domain protein CAL interacts with mGluR5a and modulates receptor expression. J Neurochem 112(3):588-598
4. Choura M, Frikha F, Kharrat N, Aifa S, Rebai A (2010) Investigating the function of three non-synonymous SNPs in EGFR gene: structural modelling and association with breast cancer. Protein J 29(1):50-54
5. Chun J, Kwon T, Lee E, Suh PG, Choi EJ, Sun Kang S (2002) The Na(?)/H(?) exchanger regulatory factor 2 mediates phosphor-ylation of serum-and glucocorticoid-induced protein kinase 1 by 3-phosphoinositide-dependent protein kinase 1. Biochem Bio-phys Res Commun 298(2):207-215 (Pubitemid 35286329)
6. Claperon A, Guedj N, Mergey M, Vignjevic D, Desbois-Mouthon C, Boissan M, Saubamea B, Paradis V, Housset C, Fouassier L (2011) Loss of EBP50 stimulates EGFR activity to induce EMT phenotypic features in biliary cancer cells. Oncogene 31(11):1376-1388. doi:10.1038/onc.2011.334
7. Curto M, Cole BK, Lallemand D, Liu CH, McClatchey AI (2007) Contact-dependent inhibition of EGFR signaling by Nf2/Merlin. J Cell Biol 177(5):893-903 (Pubitemid 46873094)
8. + exchanger regulatory factor) gene mutations in human breast cancer. Oncogene 23(53):8681-8687 (Pubitemid 39576475)
9. DiCamillo SJ, Carreras I, Panchenko MV, Stone PJ, Nugent MA, Foster JA, Panchenko MP (2002) Elastase-released epidermal growth factor recruits epidermal growth factor receptor and extracellular signal-regulated kinases to down-regulate tropoe-lastin mRNA in lung fibroblasts. J Biol Chem 277(21):18938-18946 (Pubitemid 34952455)
10. Fedor-Chaiken M, Hein PW, Stewart JC, Brackenbury R, Kinch MS (2003) E-cadherin binding modulates EGF receptor activation. Cell Commun Adhes 10(2):105-118 (Pubitemid 38035559)
11. Foley J, Nickerson NK, Nam S, Allen KT, Gilmore JL, Nephew KP, Riese DJ 2nd (2010) EGFR signaling in breast cancer: bad to the bone. Semin Cell Dev Biol 21(9):951-960
12. Forni C, Braglia R, Lentini A, Nuccetelli M, Provenzano B, Tabolacci C, Beninati S (2009) Role of transglutaminase 2 in quercetin-induced differentiation of B16-F10 murine melanoma cells. Amino Acids 36(4):731-738
13. Fouassier L, Rosenberg P, Mergey M, Saubamea B, Claperon A, Kinnmain N, Chignard N, Jacobsson-Ekman G, Strandvik B, Rey C et al (2009) Ezrin-radixin-moesin-binding phosphoprotein (EBP50), an estrogen-inducible scaffold protein, contributes to biliary epithelial cell proliferation. Am J Pathol 174(3):869-880
14. Fujikawa A, Chow JP, Shimizu H, Fukada M, Suzuki R, Noda M (2007) Tyrosine phosphorylation of ErbB4 is enhanced by PSD95 and repressed by protein tyrosine phosphatase receptor type Z. J Biochem 142(3):343-350 (Pubitemid 350221837)
15. Hsu J-M, Chen C-T, Chou C-K, Kuo H-P, Li L-Y, Lin C-Y, Lee H-J, Wang Y-N, Liu M, Liao H-W et al (2011) Crosstalk between Arg 1175 methylation and Tyr 1173 phosphorylation negatively modulates EGFR-mediated ERK activation. Nat Cell Biol 13(2):174-181
16. Hu CA, Khalil S, Zhaorigetu S, Liu Z, Tyler M, Wan G, Valle D (2008) Human Delta1-pyrroline-5-carboxylate synthase: function and regulation. Amino Acids 35(4):665-672
17. Kim H, Lim HY (2011) Novel EGFR-TK inhibitor EKB-569 inhibits hepatocellular carcinoma cell proliferation by AKT and MAPK pathways. J Korean Med Sci 26(12):1563-1568
18. Kim SW, Hayashi M, Lo JF, Yang Y, Yoo JS, Lee JD (2003) ADP-ribosylation factor 4 small GTPase mediates epidermal growth factor receptor-dependent phospholipase D2 activation. J Biol Chem 278(4):2661-2668 (Pubitemid 36801346)
19. Klapper LN, Kirschbaum MH, Sela M, Yarden Y (2000) Biochemical and clinical implications of the ErbB/HER signaling network of growth factor receptors. Adv Cancer Res 77:25-79 (Pubitemid 29439302)
20. Kolibaba KS, Druker BJ (1997) Protein tyrosine kinases and cancer. Biochim Biophys Acta 1333(3):F217-F248 (Pubitemid 28015315)
21. Konno R, Okamura T, Kasai N, Summer KH, Niwa A (2009) Mutant rat strain lacking D-amino-acid oxidase. Amino Acids 37(2):367-375
22. Kreimann EL, Morales FC, de Orbeta-Cruz J, Takahashi Y, Adams H, Liu TJ, McCrea PD, Georgescu MM (2007) Cortical stabilization of beta-catenin contributes to NHERF1/EBP50 tumor suppressor function. Oncogene 26(36):5290-5299 (Pubitemid 47237631)
23. + exchanger regulatory factor stabilizes epidermal growth factor receptors at the cell surface. Mol Biol Cell 15(12):5470-5480 (Pubitemid 39564739)
24. Lim YC, Cha YY (2011) Epigallocatechin-3-gallate induces growth inhibition and apoptosis of human anaplastic thyroid carcinoma cells through suppression of EGFR/ERK pathway and cyclin B1/CDK1 complex. J Surg Oncol doi. doi:10.1002/jso.21999
25. Musgrove EA (2004) Wnt signalling via the epidermal growth factor receptor: a role in breast cancer? Breast Cancer Res 6(2):65-68 (Pubitemid 38324844)
26. Olayioye MA, Neve RM, Lane HA, Hynes NE (2000) The ErbB signaling network: receptor heterodimerization in development and cancer. EMBO J 19(13):3159-3167 (Pubitemid 30428195)
27. Osaki LH, Figueiredo PM, Alvares EP, Gama P (2011) EGFR is involved in control of gastric cell proliferation through activation of MAPK and Src signalling pathways in early-weaned rats. Cell Prolif 44(2):174-182
28. + exchanger regulatory factor 1 (NHERF1). Breast Cancer Res 8(6):R63
29. + exchanger regulatory factor 1 inhibits platelet-derived growth factor signaling in breast cancer cells. Breast Cancer Res 10(1):R5
30. Salomon DS, Brandt R, Ciardiello F, Normanno N (1995) Epidermal growth factor-related peptides and their receptors in human malignancies. Crit Rev Oncol Hematol 19(3):183-232
31. Shibata T, Chuma M, Kokubu A, Sakamoto M, Hirohashi S (2003) EBP50, a beta-catenin-associating protein, enhances Wnt signaling and is over-expressed in hepatocellular carcinoma. Hepatology 38(1):178-186 (Pubitemid 36775809)
32. Suzuki T, Fujii A, Ohya J, Amano Y, Kitano Y, Abe D, Nakamura H (2007) Pharmacological characterization of MP-412 (AV-412), a dual epidermal growth factor receptor and ErbB2 tyrosine kinase inhibitor. Cancer Sci 98(12):1977-1984 (Pubitemid 350002206)
33. Takahashi Y, Morales FC, Kreimann EL, Georgescu M-M (2006) PTEN tumor suppressor associates with NHERF proteins to attenuate PDGF receptor signaling. EMBO J 25(4):910-920 (Pubitemid 43292451)
34. Takeuchi A, Mishina Y, Miyaishi O, Kojima E, Hasegawa T, Isobe K (2003) Heterozygosity with respect to Zfp148 causes complete loss of fetal germ cells during mouse embryogenesis. Nat Genet 33(2):172-176 (Pubitemid 36177069)
35. Theisen CS, Wahl JK 3rd, Johnson KR, Wheelock MJ (2007) NHERF links the N-cadherin/catenin complex to the platelet-derived growth factor receptor to modulate the actin cytoskeleton and regulate cell motility. Mol Biol Cell 18(4):1220-1232 (Pubitemid 46626617)
36. Valiente M, Andres-Pons A, Gomar B, Torres J, Gil A, Tapparel C, Antonarakis SE, Pulido R (2005) Binding of PTEN to specific PDZ domains contributes to PTEN protein stability and phos-phorylation by microtubule-associated serine/threonine kinases. J Biol Chem 280(32):28936-28943 (Pubitemid 41161339)
37. Wang L, Pan Y, Dai JL (2004) Evidence of MKK4 pro-oncogenic activity in breast and pancreatic tumors. Oncogene 23(35):5978-5985 (Pubitemid 39093542)
38. Wheeler DS, Barrick SR, Grubisha MJ, Brufsky AM, Friedman PA, Romero G (2011) Direct interaction between NHERF1 and Frizzled regulates beta-catenin signaling. Oncogene 30(1):32-42
39. Yang S, Qu S, Perez-Tores M, Sawai A, Rosen N, Solit DB, Arteaga CL (2006) Association with HSP90 inhibits Cbl-mediated down-regulation of mutant epidermal growth factor receptors. Cancer Res 66(14):6990-6997 (Pubitemid 44197674)
40. Zheng J, Shen H, Xiong Y, Yang X, He J (2010a) The beta1-adrenergic receptor mediates extracellular signal-regulated kinase activation via Galphas. Amino Acids 38(1):75-84
41. Zheng JF, Sun LC, Liu H, Huang Y, Li Y, He J (2010b) EBP50 exerts tumor suppressor activity by promoting cell apoptosis and retarding extracellular signal-regulated kinase activity. Amino Acids 38(4):1261-1268